abstract |
(57) Summary Disclosed are novel pyrrolidine compounds of formula (I) that are useful for inhibiting the function of type IV phosphogesterase (PDE-IV), as well as methods for making them. Applications in treating inflammatory diseases or other diseases associated with increased levels of cytokines, as well as diseases of the central nervous system (CNS) are also disclosed. |